- Home
- GALT vs CCLD Comparison
GALT vs CCLD Comparison
Compare GALT & CCLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GALT
- CCLD
- Stock Information
- Founded
- GALT 2000
- CCLD 1999
- Country
- GALT United States
- CCLD United States
- Employees
- GALT N/A
- CCLD N/A
- Industry
- GALT Biotechnology: Pharmaceutical Preparations
- CCLD Computer Software: Prepackaged Software
- Sector
- GALT Health Care
- CCLD Technology
- Exchange
- GALT Nasdaq
- CCLD Nasdaq
- Market Cap
- GALT 83.5M
- CCLD 87.2M
- IPO Year
- GALT N/A
- CCLD 2014
- Fundamental
- Price
- GALT $2.60
- CCLD $2.50
- Analyst Decision
- GALT Buy
- CCLD Buy
- Analyst Count
- GALT 2
- CCLD 2
- Target Price
- GALT $6.00
- CCLD $3.00
- AVG Volume (30 Days)
- GALT 1.2M
- CCLD 503.5K
- Earning Date
- GALT 08-12-2025
- CCLD 08-12-2025
- Dividend Yield
- GALT N/A
- CCLD N/A
- EPS Growth
- GALT N/A
- CCLD N/A
- EPS
- GALT N/A
- CCLD N/A
- Revenue
- GALT N/A
- CCLD $112,507,000.00
- Revenue This Year
- GALT N/A
- CCLD $2.74
- Revenue Next Year
- GALT N/A
- CCLD $7.52
- P/E Ratio
- GALT N/A
- CCLD N/A
- Revenue Growth
- GALT N/A
- CCLD N/A
- 52 Week Low
- GALT $0.73
- CCLD $1.14
- 52 Week High
- GALT $3.90
- CCLD $4.84
- Technical
- Relative Strength Index (RSI)
- GALT 70.66
- CCLD 68.67
- Support Level
- GALT $1.28
- CCLD $2.05
- Resistance Level
- GALT $1.36
- CCLD $2.56
- Average True Range (ATR)
- GALT 0.33
- CCLD 0.14
- MACD
- GALT 0.18
- CCLD 0.03
- Stochastic Oscillator
- GALT 52.40
- CCLD 89.66
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About CCLD CareCloud Inc.
CareCloud Inc is a healthcare information technology company. The company provides a full suite of proprietary cloud-based solutions and related business services. Its Software-as-a-Service platforms include practice management (PM), electronic health record (EHR), business intelligence, patient experience management (PXM) solutions, and robotic processing automation (RPA) bots, along with complementary software tools and business services such as revenue cycle management (RCM), premiere healthcare consulting and implementation services, and on-demand workforce staffing capabilities for high-performance medical groups and health systems nationwide. The operating segments of the group are Healthcare IT, which is the key revenue-generating segment, and Medical Practice Management.